Skip to content
Aju.News
Menu
Korea
World
Technology
Business
Sports
Entertainment
Health
Aju.News
Menu
Korea
World
Technology
Business
Sports
Entertainment
Health
drugKimria
[KJA뉴스통신] Chimeric antigen receptor T cell anticancer drug’Kimria’ approved in Korea
Korea Food and Drug Administration, Novartis CAR-T anticancer drug’Kimria’ approved in Korea
Novartis anticancer drug’Kimria’ approved for the first high-tech biopharmaceutical in Korea
![[KJA뉴스통신] Chimeric antigen receptor T cell anticancer drug’Kimria’ approved in Korea](http://gtr.xza.kr/imgdata/gtr_xza_kr/202103/50-20210305130421.png "[KJA뉴스통신] Chimeric antigen receptor T cell anticancer drug’Kimria’ approved in Korea")
